Jeff Fairman - 11 Mar 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
11 Mar 2022
Net transactions value
-$255,000
Form type
4
Filing time
15 Mar 2022, 21:09:47 UTC
Previous filing
04 Mar 2022
Next filing
07 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale $255,000 -10,000 -2.9% $25.50 331,227 11 Mar 2022 By Fairman Family Trust F1
holding PCVX Common Stock 16,629 11 Mar 2022 Direct
holding PCVX Common Stock 50,000 11 Mar 2022 By AF 2020 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.